title: Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.
authors.forename: S
authors.initials: S
authors.lastname: Slavin
authors.forename: E
authors.initials: E
authors.lastname: Naparstek
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: Y
authors.initials: Y
authors.lastname: Kapelushnik
authors.forename: A
authors.initials: A
authors.lastname: Ackerstein
authors.forename: R
authors.initials: R
authors.lastname: Or
mesh_terms: D016026:Bone Marrow Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive; D007938:Leukemia / Q000628:therapy*; D017710:Lymphocyte Transfusion; D012008:Recurrence